Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix
blend
Dosage Range
Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix is found in 3 supplement products from 1 brands. Dosages range from 550 to 550 mg, with an average of 550. The most common form is Capsule.
Top 5 Highest-Dosage Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix Supplements
- Natural Glucose by Life Extension — 550 mg
All Products
showing 1 of 1| Product | Brand | Amount | Daily Value | Form |
|---|---|---|---|---|
| Natural Glucose | Life Extension | 550 mg | — | Capsule |
Frequently Asked Questions
How many products contain Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix?
There are 3 supplement products containing Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix from 1 brands in the NIH DSLD database.
What is the average Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix dosage?
The average Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix dosage across supplement products is 550 mg. Dosages range from 550 to 550 mg.
What is the most common form for Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix supplements?
The most common product form for Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix supplements is Capsule.
What brands make Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix supplements?
There are 1 brands that make supplements containing Phase 3 Sucrase Inhibitor L-Arabinose and Chromium GlycoProtein Matrix in the NIH DSLD database.
Related Ingredients
Explore More
Quick Facts
- Products
- 3
- Brands
- 1
- Avg Dose
- 550 mg
- Common Form
- Capsule
- Category
- blend